← Back to Clinical Trials
Recruiting NCT06963086

NCT06963086 Implementing an Eating Disorder Prevention Program for Youth in Nova Scotia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06963086
Status Recruiting
Phase
Sponsor Susan Gamberg
Condition Body Image
Study Type INTERVENTIONAL
Enrollment 120 participants
Start Date 2026-01-14
Primary Completion 2026-09

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 22 Years
Study Type INTERVENTIONAL
Interventions
Eating disorder prevention program (the Body Project)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 120 participants in total. It began in 2026-01-14 with a primary completion date of 2026-09.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to evaluate the Body Project, which is an eating disorder prevention program for youth 15-22 years old. The main question it aims to answer is 'Can an eating disorder prevention program, specifically the Body Project, be successfully delivered to youth in Nova Scotia'? This study will determine the feasibility of implementing the Body Project in Nova Scotia by assessing the following objectives: 1. Acceptability (how well the Body Project is received by, and the extent to which it is perceived as meeting the needs of, youth in Nova Scotia). 2. Demand (the extent to which youth in Nova Scotia are interested in and willing to engage with the program). 3. Integration (the extent to which the Body Project is judged as feasible by the group facilitators). 4. Effectiveness (the extent to which the Body Project reduces eating disorder risk factors in youth in Nova Scotia). Participants will: * Attend a total of 4-4.5 hours of Body Project group sessions, which are led by peer mentors. * Complete outcome measure questionnaires before their first session and after their last session. * Participate in a focus group with their session group members after their last session.

Eligibility Criteria

Inclusion Criteria: * Self-identify as a girl/woman. * Be between the ages of 15-22 years old. * For inclusion in an in-person group, an individual must be currently enrolled as a student at the school where they will participate in sessions. * For inclusion in a virtual BP group, an individual must live in and/or attend school in Nova Scotia, and have access to a computer (e.g., laptop, desktop computer, cellphone) with internet connection and a webcam that can be used in a private location (if a participant does not have a private location to use when attending sessions, they will be asked to wear headphones). * Able to complete English computer-based self-report questionnaires (with adequate accommodation, if necessary). * Provides informed consent (or verbal assent with informed consent provided by parent/guardian). Exclusion Criteria: * Previous participation in the Body Project.

Contact & Investigator

Central Contact

Susan Gamberg, PhD

✉ susan.gamberg@nshealth.ca

📞 902-473-2239

Principal Investigator

Susan Gamberg, PhD

PRINCIPAL INVESTIGATOR

Nova Scotia Health Authority

Frequently Asked Questions

Who can join the NCT06963086 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 22 Years, studying Body Image. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06963086 currently recruiting?

Yes, NCT06963086 is actively recruiting participants. Contact the research team at susan.gamberg@nshealth.ca for enrollment information.

Where is the NCT06963086 trial being conducted?

This trial is being conducted at Halifax, Canada.

Who is sponsoring the NCT06963086 clinical trial?

NCT06963086 is sponsored by Susan Gamberg. The principal investigator is Susan Gamberg, PhD at Nova Scotia Health Authority. The trial plans to enroll 120 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology